Alpha, Kenneth M.
HRN: 25-43-02 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/02/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/02/2024
07/09/2024
IV
4.5gm
Q6H
S/P ExLap
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes